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Background: Compensation of brain injury in multiple sclerosis (MS) may in part work through mechanisms
involving neuronal plasticity on local and interregional scales. Mechanisms limiting excessive neuronal activity may
have special significance for retention and (re-)acquisition of lost motor skills in brain injury. However, previous
neurophysiological studies of plasticity in MS have investigated only excitability enhancing plasticity and results from
neuroimaging are ambiguous. Thus, the aim of this study was to probe long-term depression-like central motor
plasticity utilizing continuous theta-burst stimulation (cTBS), a non-invasive brain stimulation protocol. Because cTBS
also may trigger behavioral effects through local interference with neuronal circuits, this approach also permitted
investigating the functional role of the primary motor cortex (M1) in force control in patients with MS.
Methods: We used cTBS and force recordings to examine long-term depression-like central motor plasticity and
behavioral consequences of a M1 lesion in 14 patients with stable mild-to-moderate MS (median EDSS 1.5,
range 0 to 3.5) and 14 age-matched healthy controls. cTBS consisted of bursts (50 Hz) of three subthreshold biphasic
magnetic stimuli repeated at 5 Hz for 40 s over the hand area of the left M1. Corticospinal excitability was probed via
motor-evoked potentials (MEP) in the abductor pollicis brevis muscle over M1 before and after cTBS. Force
production performance was assessed in an isometric right thumb abduction task by recording the number of hits
into a predefined force window.
Results: cTBS reduced MEP amplitudes in the contralateral abductor pollicis brevis muscle to a comparable extent in
control subjects (69 ± 22% of baseline amplitude, p < 0.001) and in MS patients (69 ± 18%, p < 0.001). In contrast, post-
cTBS force production performance was only impaired in controls (2.2 ± 2.8, p = 0.011), but not in MS patients
(2.0 ± 4.4, p = 0.108). The decline in force production performance following cTBS correlated with corticomuscular
latencies (CML) in MS patients, but did not correlate with MEP amplitude reduction in patients or controls.
Conclusions: Long-term depression-like plasticity remains largely intact in mild-to-moderate MS. Increasing brain
injury may render the neuronal networks less responsive toward lesion-induction by cTBS.
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Several distinct mechanisms are believed to contribute to
the compensation of brain injury in multiple sclerosis
(MS). Apart from processes of tissue repair at the cellular
level, neuronal plasticity may play a major role [1-6].
Synapse-specific Hebbian forms of plasticity, such as
long-term potentiation (LTP) and depression (LTD), are
supposed to represent potentially rate-limiting steps on
the way to successful long-term reorganization of the* Correspondence: zeller_d@klinik.uni-wuerzburg.de
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reproduction in any medium, provided the orbrain [7,8]. Rapid onset plasticity of neuronal connec-
tions likely involves both enhancement and depression of
synaptic efficacy. We previously showed that LTP-like
motor plasticity remains intact in mild-to-moderately
afflicted MS patients [9]. However, it remains unknown if
excitability decreasing, i.e. LTD-like plasticity is compro-
mised in MS patients. This type of plasticity may be par-
ticularly important because it is challenged when
neuronal activity needs to be focussed during the process
of acquiring or regaining a specific skill. Functional mag-
netic resonance (fMRI) studies addressing short-term
adaptation, i. e. the attenuation of the fMRI responsetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Zeller et al. BMC Neurology 2012, 12:92 Page 2 of 7
http://www.biomedcentral.com/1471-2377/12/92during repeated motor task execution, provided incon-
sistent results. When studying fMRI activation patterns
that were associated with performance of voluntary
thumb movements before and after motor training, Mor-
gen and colleagues [5] found that MS patients lack the
typical task-specific training-dependent reductions in ac-
tivation of some contralateral cortical regions that they
observed in healthy controls. However, in another recent
fMRI study, regional brain activation induced by exter-
nally cued right hand tapping decayed normally over
consecutive runs in MS patients [10]. The extent of this
decay was not influenced by a modest disease progres-
sion observed over one year [10]. Thus, an assessment of
LTD-like plasticity in MS by neurophysiological means is
of special interest because it taps more directly into
mechanisms limiting neuronal excitation and might po-
tentially translate into behavioural treatment strategies.
In the present study, we tested LTD-like rapid-onset
central motor plasticity in patients with MS and in
healthy controls using an excitability-decreasing tran-
scranial magnetic stimulation protocol (continuous
theta-burst stimulation, cTBS). cTBS has previously been
shown to induce a depression of corticospinal excitability
whose physiological properties resemble those observed
for LTD as studied in animal preparations [11-13]. The
effects of the cTBS intervention were assessed neuro-
physiologically (motor evoked potentials, MEPs) and be-
haviourally (force production performance, FPP). We







1 23 m 4 RRMS
2 23 m 7 RRMS
3 32 m 9 RRMS
4 32 m 6 RRMS
5 34 m 4 RRMS
6 48 m 3 RRMS
7 23 f 6 RRMS
8 25 f 6 RRMS
9 25 f 8 RRMS
10 28 f 7 RRMS
11 29 f 1 RRMS
12 31 f 3 RRMS
13 33 f 9 RRMS
14 36 f 9 RRMS
Mean 30.1 5.9
± SD ± 6.8 ± 2.5
*Patients listed by gender and age.
m=male; f = female; EDSS = expanded disability status scale; RRMS = Relapsing-Rem
with immunomodulators; FING= fingolimod; GA =glatiramer acetate; IF = interferon
placebo; patient participated in a randomized controlled treatment trial with undiscplasticity and responsiveness toward an interfering inter-
vention over the primary motor cortex (M1) are compro-
mised in patients with MS.Methods
Patients and healthy controls
Fourteen patients with definite MS aged between 23 and
48 years (30.1± 6.8 years, mean±SD) were recruited from
the outpatient clinic of the Clinical Research Group for
MS at the Department of Neurology, University of Würz-
burg. Eleven of these patients had already been included in
a previous study [14]. The present experiments were done
at least six weeks after those previous tests. The recruiting
neurologist was not informed about the scientific hypoth-
esis of this study as to avoid any selection bias. A full
neurologic examination was done including the Expanded
Disability Status Scale (EDSS) [15]. Patients were eligible
for the study if the following inclusion criteria were met: 1)
age between 18 and 60 years, 2) stable clinical condition
within the past three months (i. e. absence of relapse, pro-
gression, or changes in therapy), 3) no medication targeting
α-adrenergic or serotonergic receptors, and 4) exclusion of
pregnancy by lab testing. All MS patients were right-
handed, according to a modified version of the Edinburgh
Inventory. Fourteen healthy controls recruited from a large
database of volunteers were matched for age, sex, and
handedness. Clinical characteristics of MS patients and
controls are summarized in Table 1.Current DMT EDSS Control no. Age
(years)
Sex
(FTY/Plac) 2.0 1 26 m
FING 2.0 2 27 m
IF 1,0 3 27 m
GA 0.0 4 33 m
NAT 3.5 5 35 m
IF 2.0 6 45 m
NAT 1.5 7 24 f
IF 1.5 8 26 f
IF 1.5 9 26 f
IF 2.0 10 26 f
IF 1.0 11 26 f
IF 1.0 12 28 f
IF 2.5 13 33 f
IF 1.5 14 45 f
Median 1.5 Mean ± 30.5
[range] [0–3.5] SD ± 6.9
itting MS; SPMS= Secondary Progressive MS; DMT=disease modifying therapy










Figure 1 (A) Representative force trajectories (on right)
obtained with isometric right thumb abductions (abductor
pollicis brevis muscle, ABP; on left). Force production
performance was assessed by the number of attempts falling within
the target force window displayed as two horizontal lines on the
computer screen. Fmax: individual maximum force. (B) Schematic
overview of the experimental procedure. cTBS, continuous theta-
burst stimulation; MEP, motor-evoked potentials; FPP, force
production performance.
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ation of Helsinki. It was approved by the Ethics commit-
tee of the Medical Faculty at the University of
Würzburg. All MS patients and control subjects gave
their written informed consent for this research study.
Transcranial magnetic stimulation (TMS) and EMG
recording
Stimulation
Focal TMS was performed using a figure-of-eight shaped
magnetic coil (C-B60 Medtronic) connected to a Mag-
Pro X100 magnetic stimulator (Medtronic A/S 2740
Skovlunde, Denmark). The pulse shape was either
monophasic or biphasic, as indicated below. The coil
was held tangentially to the skull with the handle point-
ing backwards and laterally at a 45° angle to the sagittal
plane. The optimal position of the magnetic coil for eli-
citing MEPs in the abductor pollicis brevis (APB) muscle
of the dominant hand was assessed over the left M1 and
digitally recorded with a neuronavigational device (see
below). At this position, termed “motor hot-spot”, the
resting motor threshold (RMT) was determined [16].
Complete relaxation of the ABP was continuously moni-
tored by visual and auditory feedback from the surface
EMG. A neuronavigational device (Brainsight, Rogue Re-
search, Montreal, Canada) was used to increase the fidel-
ity of stably positioning the TMS coil over the course of
an experiment.
Electromyographic recordings
Surface EMG activity was recorded from the right APB
muscle using surface electrodes in a belly-tendon mon-
tage. Raw signals were amplified using a differential
amplifier (CED 1902, Cambridge Electronic Design,
Cambridge, UK) and bandpass-filtered between 1 and
2000 Hz. EMG signals were sampled at 5000 Hz, digi-
tized using an analogue–digital converter (CED 1401
plus, Cambridge Electronic Design, Cambridge, UK) and
stored in a laboratory computer.
Continuous theta-burst stimulation (cTBS)
cTBS was performed similar to the protocol described by
Huang et al. [12]. Trains of magnetic pulses containing 3
TMS pulses of 50 Hz (i. e. with an interval of 20 ms be-
tween each stimulus) were repeated at 200 ms intervals
(i. e., 5 Hz) for a duration of 40 sec (total of 600 pulses).
Stimulus intensity was set to 0.7 x RMT as assessed in
the right APB muscle [17]. In control subjects, an add-
itional “sham” stimulation at 2% of the maximal stimula-
tor output was performed in a pseudorandomized and
counterbalanced design. For cTBS, the pulse shape was
biphasic. As a safety measure, the EMG of biceps brachii
muscle was continuously monitored during cTBS to de-
tect potential spread of excitation to proximal muscles.Force production performance (FPP)
FPP was assessed as described previously [18]. Briefly,
subjects performed brisk isometric abductions with the
right thumb against a force transducer (Grass CP122A,
Grass Instruments CO, West Warwick, RI). The force
transducer was adjusted such that it could be easily and
immediately activated by pure thumb abduction move-
ments. First, the subject’s maximum force was obtained
as the mean of five consecutive trials of maximal force
production. A target force window was then defined as
the range between 30% and 40% of the subject’s max-
imum force. The subject performing the test was asked
to focus on the computer screen and instructed to posi-
tion the force curve between the two horizontal lines by
appropriate abductor muscle contraction (Figure 1A).
Each block consisted of 30 metronome paced isometric
thumb abductions at 0.5 Hz. The number of successful
attempts falling within the target force window was
taken as a measure of performance.
Experimental procedure
Patients and control subjects were seated comfortably in
an armchair. The cortical “motor hot-spot” was obtained
as described above. The functionally defined hand motor
Table 2 Baseline measurements in MS patients and
controls
Motor test MS patients Controls p value
Corticomuscular latency,
CML (msec)
21.9 ± 1.7 20.8 ± 1.0 0.052
Force production performance
at baseline
14.3 ± 3.5 18.4 ± 4.1 0.009
Resting motor threshold,
monophasic (%)
54.2 ± 10.9 50.8 ± 11.6 0.428
Resting motor threshold,
biphasic (%)
37.4 ± 5.6 41.6 ± 11.7 0.236
MEP amplitudes
at baseline (mV)
1.5 ± 1.0 1.2 ± 0.8 0.450
MEP=motor evoked potential.
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the anatomical location according to the landmarks
described previously [19], was used to mark the final M1
stimulation position in the digital data set. At this site,
the RMT was determined for both monophasic and bi-
phasic pulse shape.
Corticospinal excitability of the APB muscle represen-
tation was probed by collecting 30 TMS pulses at a
stimulus intensity of 1.3 x RMT and a stimulation rate
of 0.1 Hz. The pulse shape was monophasic. MEP
responses were recorded from the right APB muscle. To
optimize FPP before any intervention, each subject per-
formed eight training blocks, separated by one minute to
avoid fatigue. Thereafter, cTBS was applied to the left
M1 area. Thirty MEP responses were collected immedi-
ately (t1) and at 40 min (t2) after cTBS. FPP was estab-
lished at 5 min, 15 min, 25 min, and 35 min after cTBS
(Figure 1B).Data analysis
FPP was assessed by the number of successful attempts
(within a block of 30 trials) falling within the target force
window. In order to assess the net effect of cTBS on
FPP, to minimize the influence of unspecific factors such
as differences in baseline performance between subjects,
and to account for learning effects and incremental per-
formance over the course of the session, we used the
FPP values of the mean of each of the eight blocks
acquired before cTBS intervention to compute a per-
formance trendline. Postinterventional performance was
compared against the extrapolation of this trendline.
cTBS-induced changes were estimated as deviations
from the linear trend of pre-interventional performance
(“delta”). For comparison with the trendline, perform-
ance was tested against unity using two-tailed one-sam-
ple t-tests. The false discovery rate (FDR) correction was
applied to control for multiple comparisons.
MEP amplitudes were measured peak-to-peak in each
individual trial. Each block of 30 MEP amplitudes was
averaged. To assess the effect of cTBS intervention on
cortical excitability, changes of MEP amplitude were
expressed as percent difference from baseline. Repeated
measure analyses of variance (ANOVARM) were used for
statistical analysis, and two-tailed t-tests for post hoc
analysis. Effects were considered significant if p < 0.05. If
not stated otherwise, all values are given as means ± SD.Figure 2 Changes in baseline-normalized MEP amplitudes of
the APB induced by cTBS (%) in 14 MS patients (dark grey
columns) and 14 matched control subjects (real cTBS: medium
grey columns; sham cTBS: light grey columns). Error bars
indicate the standard error of the mean (SEM). Asterisks indicate
significant difference from baseline.Results
Demographic and clinical features of MS patients are
summarized in Table 1. As expected, corticomuscular la-
tency (CML) to the APB muscle of the right hand in MS
patients tended to be increased as compared to healthy
controls (see Table 2).Changes of corticospinal excitability by cTBS
Baseline measurements
RMT and MEP amplitudes in the APB muscle before
cTBS were comparable between MS patients and age-
matched controls (see Table 2).cTBS-induced effects
Changes in baseline-normalized MEP amplitudes of APB
induced by cTBS are illustrated in Figure 2. In healthy
controls, cTBS of the left M1 modulated the magnitude of
MEP amplitudes of the contralateral APB muscle depend-
ing on the stimulation mode. ANOVARM (MODE (real,
sham) x TIME (t0,t1,t2)) revealed a significant MODE×
TIME interaction (F(2,52) = 10.8; p < 0.001) while the
(within-subjects) factor TIME was not significantly differ-
ent. Post hoc testing revealed that there was a significant
suppression of contralateral MEP amplitudes when real
cTBS (0.7 x RMT) was applied (t1: 69± 22%; p < 0.001;
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(t1: 110 ± 28%; p = 0.203; t2: 115 ± 36%; p = 0.142).
In MS patients and controls, cTBS (0.7 x RMT) of the
left M1 induced a decrease of the MEP amplitudes of the
contralateral APB. ANOVARM (HEALTH (multiple scler-
osis, MS; controls, CTRL) x TIME (t0,t1,t2)) revealed sig-
nificant effects of the (within-subjects) factor TIME (F
(2,52) = 27.3, p < 0.001), but not of the TIME x HEALTH
interaction (F(2,52) = 0.2, p = 0.985). The (between-sub-
jects) factor HEALTH (F(1,26) = 0.01, p = 0.936) was not
significant. Upon exploratory post hoc testing, cTBS
effects were found significant for epochs t1 (69± 22%,
p < 0.001) and t2 (77 ± 21%, p= 0.001) in controls, and
similarly for epoch t1 (69 ± 18%, p < 0.001) and t2
(75 ± 30, p = 0.008) in MS patients.Changes of force production performance (FPP) by cTBS
At baseline, MS patients performed worse than controls
in the force production task (see Table 2). However, over
the course of the eight training blocks, improvements of
FPP were statistically comparable between MS patients
and healthy controls (p = 0.183; see Figure 3), MS
patients and controls reached similar performance levels
(MS patients: 19.3 ± 4.7; controls: 20.9 ± 2.1; p = 0.240).
Following cTBS, FPP showed a significant temporary de-
terioration in controls (delta: 2.2 ± 2.8, p = 0.011, signifi-
cant after FDR correction), but not in MS patients
(2.0 ± 4.4, p = 0.108) at t1. There were no significant FPP
changes following sham cTBS in the control subjects
(0.5 ± 3.5, p = 0.579; see Figure 3).Figure 3 Changes of force production performance over the
course of the eight training blocks (“learned”) and at four time
points following cTBS in 14 MS patients (dark grey columns)
and 14 matched control subjects (real cTBS: medium grey
columns; sham cTBS: light grey columns). Error bars indicate the
standard error of the mean (SEM). Asterisks indicate significant
difference from baseline after proper training (see methods;
“learned”) and from the extrapolated performance trendline at
different time intervals (in minutes; “after cTBS”), respectively
(two-tailed, one-sample t-test, after FDR correction).Correlation of cTBS-induced FPP decline with CML
There were no correlations between the changes in
baseline-normalized MEP amplitudes and FPP changes
following cTBS over M1 in MS patients and controls.
However, the FPP decline following cTBS over M1 cor-
related strongly with CML in MS patients (r = 0.634,
p = 0.015; Figure 4), but not in healthy controls.
Discussion
The present study has examined LTD-like rapid-onset
central motor plasticity and functional consequences of
a transient virtual M1 lesion induced by cTBS in mild-
to-moderately afflicted MS patients and healthy controls.
cTBS decreased cortical excitability for a duration of
about 30 min in patients and controls to a similar de-
gree. In contrast, cTBS impaired force production per-
formance (FPP) significantly for at least 5 min only in
healthy controls, but not in MS patients.
TBS-induced plasticity shares properties with synaptic
LTD [11-13] although this has been questioned by some
authors [20]. The present findings suggest that LTD-like
plasticity remains largely intact in MS patients. Along
with previous observations [9], these findings provide
evidence that rapid-onset synaptic plasticity as assessed
by neurophysiological means is not compromised in
mild-to-moderately afflicted MS patients. Previous func-
tional MRI (fMRI) studies probing rapid-onset plasticity
in comparably afflicted MS patients provided inconsist-
ent results: One recent fMRI study has demonstrated a
decay of regional brain activation by a tapping task over
consecutive runs, with similar changes in MS patients
and matched controls [10]. In contrast, another study
has shown absent task-specific reductions in fMRI acti-
vation of some contralateral cortical regions after motor
training in MS patients [5]. However, while the first
study compared activation patterns of a simple hand
tapping paradigm before and after training of this move-
ment, the latter assessed changes in activation for aFigure 4 Correlation of changes of the force production
performance following cTBS over M1 with corticomuscular
latency (CML) in 14 MS patients.
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(thumb extension). Attenuation of the blood-oxygen-
level dependent (BOLD) response during repeated exe-
cution of an over-learnt motor task may reflect neuronal
plasticity, but may also simply result from reduction of
attention with time. Therefore, physiological mechan-
isms cannot be directly inferred from functional imagin-
ing studies. By employing a brain stimulation technique,
the present study allows a less ambiguous, more direct
insight into LTD-like phenomena in MS.
MS-related demyelination, axonal damage, and loss of
neuronal synapses may critically interfere with basic pre-
requisites for the expression of Hebbian as well as cTBS-
induced plasticity (see also [9]). In animal models, the
endocannabinoid system has been shown to mediate
LTD in the neocortex, with CB1 receptors being prom-
inently involved [21,22]. Importantly, the endocannabi-
noid system is strongly dysregulated in acutely relapsing
MS [23]. Therefore, preserved capacity to express LTD-
like central motor plasticity may either point to pre-
served endocannabinoid signalling during stable phases
of the disease or to recruitable alternative molecular
pathways in MS patients, probably converging towards
negative feedback mechanisms at GABAergic and dopa-
minergic synapses [24].
Although the FPP changes following cTBS over M1
were not statistically significant in MS patients, FPP
changes were strongly correlated with CML in this
group: Surprisingly, and perhaps counterintuitively, the
more CML was prolonged, the less evident was the
impairment of FPP by cTBS applied to M1. Although
functional activation of non-canonical motor regions
may contribute to maintaining motor performance in
MS patients [14], it appears highly unlikely that the
functional role of M1 has completely be substituted by
non-canonical motor regions. Similarly, although the
functional redundancy of the motor system (“degeneracy”)
might decrease its susceptibility to disruption of one of its
nodes (cf. refs. [25,26]), it is unlikely that degeneracy
increases with higher lesion load because MS-related
pathology does not affect only one node, but multiple
brain regions in parallel. We favour, therefore, the alterna-
tive possibility that increasing brain injury may render
the neuronal networks less responsive toward lesion-
induction by cTBS. According to this idea, for TMS to
induce behavioural interference, it must act on suscep-
tible brain regions. In healthy people, the temporary
behavioral deterioration following off-line cTBS possibly
depends on the capacity of cortical circuits to express
“noisy oscillations” in response to TMS, thereby decreas-
ing the signal-to-noise ratio of highly organized cortical
circuits [27]. In this way, the presence of significant CNS
injury (as indexed by prolonged CML) has reduced the
capacity of inhibitory interneurons to initiate “noisyoscillations”. This mechanism is consistent with the lack
of correlation between cTBS-induced changes of MEP
amplitudes and FPP, and provides additional support for
conclusions derived from parallel studies of physiology
and motor behaviour in healthy subjects [28], showing
that mechanisms underlying behavioural effects of cTBS
are distinct from those induced at excitatory synaptic
connections.
A potential limitation of this study might be the linear
extrapolation of the performance trendline, which was
used in order to assess the net effect of cTBS on the
FPP. However, prolonged motor training was unlikely to
lead to stabile performance due to fatigue and/or lapse
of concentration in healthy subjects, and possible even
much more in MS patients. Decreasing task difficulty
was not an alternative option, as this might have
resulted in reduced sensitivity of the task towards dis-
ruption by TMS. Therefore, our paradigm can be viewed
as a trade-off between feasibility, reduced resilience of
MS patients and best possible sensitivity towards a
virtual lesion.
Another limitation of our study is the degree of disease
severity of MS patients. While LTD-like plasticity may be
retained in mild-to-moderately affected MS patients, it
cannot be ruled out that LTD-like plasticity may be
reduced in patients with more severe CNS injury.Conclusion
In conclusion, taking into consideration that neither
LTP- [9], nor LTD-like (this study) rapid-onset central
motor plasticity is impaired in mild-to-moderately
affected MS patients, rehabilitation efforts may need to
focus on mechanisms supporting the later rather than
the early stages of central motor plasticity.
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